Passive Immunisation Cinpanemab (BIIB054), a human-derived monoclonal antibody which preferentially binds extracellular aggregated alpha-synuclein, failed to meet any primary and secondary endpoints over 52 weeks in a phase 2 trial [97], despite having shown safety, tolerability, and favourable pharmacokinetics in a previous phase 1 trial [98]
BPI Labs is not just another 503B outsourcing facility
Golden 48 Hours After Opening Once the aluminum seal is broken, the countdown begins
Community wellness discussions should be evaluated with the same lens as the platform itself: educational peer sharing, not clinical guidance
The Ultimate Guide for Donors GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are now used by millions of women in the donor age range
It is also significant in supporting the continuation of physical effort and generating more work